QAS.AI is a medical device company [3] that develops real-time intraoperative artificial intelligence for neurovascular care [2]. The company's platform integrates into angiography workflow and provides actionable treatment insight during procedures while patients remain on the operating table [2]. QAS.AI initially focuses on intracranial aneurysm treatment, with the goal of helping physicians reduce uncertainty, improve procedural decisions, and decrease retreatments [2]. The company is a spinout from the University at Buffalo [2] and has conducted clinical integration work across leading imaging environments [2]. QAS.AI was founded in 2020 [2] and has secured non-dilutive funding [2].
Something wrong or missing? Send a correction. Fixed within 24 hours.